5
|
Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Varoli L, Calonghi N, Cappadone C, Farruggia G, Zini M, Stefanelli C, Masotti L, Radin NS, Shoemaker RH. New Antitumor Imidazo[2,1-b]thiazole Guanylhydrazones and Analogues1. J Med Chem 2008; 51:809-16. [DOI: 10.1021/jm701246g] [Citation(s) in RCA: 111] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Aldo Andreani
- Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Dipartimento di Biochimica “G. Moruzzi”, Università di Bologna, Via Irnerio 48, 40126 Bologna, Italy, Molecular & Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, Michigan 48109, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, Frederick, Maryland 21702
| | - Silvia Burnelli
- Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Dipartimento di Biochimica “G. Moruzzi”, Università di Bologna, Via Irnerio 48, 40126 Bologna, Italy, Molecular & Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, Michigan 48109, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, Frederick, Maryland 21702
| | - Massimiliano Granaiola
- Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Dipartimento di Biochimica “G. Moruzzi”, Università di Bologna, Via Irnerio 48, 40126 Bologna, Italy, Molecular & Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, Michigan 48109, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, Frederick, Maryland 21702
| | - Alberto Leoni
- Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Dipartimento di Biochimica “G. Moruzzi”, Università di Bologna, Via Irnerio 48, 40126 Bologna, Italy, Molecular & Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, Michigan 48109, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, Frederick, Maryland 21702
| | - Alessandra Locatelli
- Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Dipartimento di Biochimica “G. Moruzzi”, Università di Bologna, Via Irnerio 48, 40126 Bologna, Italy, Molecular & Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, Michigan 48109, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, Frederick, Maryland 21702
| | - Rita Morigi
- Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Dipartimento di Biochimica “G. Moruzzi”, Università di Bologna, Via Irnerio 48, 40126 Bologna, Italy, Molecular & Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, Michigan 48109, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, Frederick, Maryland 21702
| | - Mirella Rambaldi
- Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Dipartimento di Biochimica “G. Moruzzi”, Università di Bologna, Via Irnerio 48, 40126 Bologna, Italy, Molecular & Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, Michigan 48109, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, Frederick, Maryland 21702
| | - Lucilla Varoli
- Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Dipartimento di Biochimica “G. Moruzzi”, Università di Bologna, Via Irnerio 48, 40126 Bologna, Italy, Molecular & Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, Michigan 48109, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, Frederick, Maryland 21702
| | - Natalia Calonghi
- Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Dipartimento di Biochimica “G. Moruzzi”, Università di Bologna, Via Irnerio 48, 40126 Bologna, Italy, Molecular & Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, Michigan 48109, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, Frederick, Maryland 21702
| | - Concettina Cappadone
- Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Dipartimento di Biochimica “G. Moruzzi”, Università di Bologna, Via Irnerio 48, 40126 Bologna, Italy, Molecular & Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, Michigan 48109, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, Frederick, Maryland 21702
| | - Giovanna Farruggia
- Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Dipartimento di Biochimica “G. Moruzzi”, Università di Bologna, Via Irnerio 48, 40126 Bologna, Italy, Molecular & Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, Michigan 48109, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, Frederick, Maryland 21702
| | - Maddalena Zini
- Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Dipartimento di Biochimica “G. Moruzzi”, Università di Bologna, Via Irnerio 48, 40126 Bologna, Italy, Molecular & Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, Michigan 48109, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, Frederick, Maryland 21702
| | - Claudio Stefanelli
- Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Dipartimento di Biochimica “G. Moruzzi”, Università di Bologna, Via Irnerio 48, 40126 Bologna, Italy, Molecular & Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, Michigan 48109, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, Frederick, Maryland 21702
| | - Lanfranco Masotti
- Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Dipartimento di Biochimica “G. Moruzzi”, Università di Bologna, Via Irnerio 48, 40126 Bologna, Italy, Molecular & Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, Michigan 48109, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, Frederick, Maryland 21702
| | - Norman S. Radin
- Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Dipartimento di Biochimica “G. Moruzzi”, Università di Bologna, Via Irnerio 48, 40126 Bologna, Italy, Molecular & Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, Michigan 48109, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, Frederick, Maryland 21702
| | - Robert H. Shoemaker
- Dipartimento di Scienze Farmaceutiche, Università di Bologna, Via Belmeloro 6, 40126 Bologna, Italy, Dipartimento di Biochimica “G. Moruzzi”, Università di Bologna, Via Irnerio 48, 40126 Bologna, Italy, Molecular & Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, Michigan 48109, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, Frederick, Maryland 21702
| |
Collapse
|